Paper172189
Oestrogen and androgen receptors in breast cancer and response to endocrine therapy.
Persijn JP and 2 others. Br Med J, 1975. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Oestrogen and androgen receptors in breast cancer and response to endocrine therapy. Papers, record 172189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/172189
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Dihydrotestosterone | Major topic |
| Estrogens | Major topic |
| Receptors, Cell Surface | Major topic |
| Castration | |
| Female | |
| Humans |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02300675 | Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy | Background |
Source ClinicalTrials.gov
References1
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|---|
| 1 | 4343152 | Characterization and assay of steroid hormone receptors and steroid-binding serum proteins by agargel electrophoresis at low temperature. | Hoppe Seylers Z Physiol Chem | 1972 | https://conductscience.org/library/papers/4343152 |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37835396 | The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37835396 | PubMed |
| 26039245 | Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. | PLoS One | 2015 | https://conductscience.org/library/papers/26039245 | PubMed |
| 21325075 | Androgen receptor expression and breast cancer survival in postmenopausal women. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21325075 | PubMed |
| 7171833 | Bilateral ovariectomy in premenopausal patients with advanced breast cancer, after the evaluation of estrogen receptors and urinary androgen excretion. | Breast Cancer Res Treat | 1982 | https://conductscience.org/library/papers/7171833 | PubMed |
| 2221994 | Androgen receptors, serum androgen levels and survival of breast cancer patients. | Arch Gynecol Obstet | 1990 | https://conductscience.org/library/papers/2221994 | PubMed |
| 208709 | Hormone receptors in breast cancer. | Br Med J | 1978 | https://conductscience.org/library/papers/208709 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/172189
GET https://conductscience.org/api/papers/v1/172189/authors